Go to ...

Nordens Ekonomi Norge

RSS Feed

17. november 2018

Novartis announces presentation of new Lutathera® NETTER-1 data at ESMO demonstrating significant improvement in PFS regardless of baseline liver tumor burden


Euroinvestor.com A/S Euroinvestor.com A/S



Novartis International AG /
Novartis announces presentation of new Lutathera® NETTER-1 data at ESMO
demonstrating significant improvement in PFS regardless of baseline liver tumor
burden
. Processed and transmitted by West Corporation.
The issuer is solely responsible for the content of this announcement.




More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
Kitron legger frem tall

Kitron satt igjen med drøye 21 millioner kroner etter 3. kvartal.

Close